CD38 Expression On CD34+Cells as a Single Flow Cytometric Parameter to Distinguish Myelodysplastic Syndromes (MDS) From Non-Clonal Cytopenias.

被引：0
|
作者：
Alhan, Canan [1 ]
Westers, Theresia. M. [1 ]
Cali, Claudia [1 ]
Ossenkoppele, Gert J. [1 ]
van de Loosdrecht, Arjan A. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1089
页数：1
相关论文
共 50 条
  • [31] Comparison of differential gene expression in unselected bone marrow and purified CD34+-cells from patients with myelodysplastic syndromes
    Neumann, M.
    Nolte, F.
    Benlasfer, O.
    Nowak, V
    Schumann, C.
    Baldus, C. D.
    Thiel, E.
    Hofmann, W-K
    ONKOLOGIE, 2010, 33 : 223 - 223
  • [32] Clonal chromosomal abnormalities in CD34+/CD38− hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
    T Bumm
    J Deininger
    A H Newell
    H Lawce
    S Olson
    M Mauro
    B Druker
    M Deininger
    Leukemia, 2010, 24 : 1525 - 1528
  • [33] Proteomic Profiling In CD34+CD38-Stem Cells and CD34+Cells From 185 Myelodysplasia Patients Using Reverse Phase Proteins Arrays (RPPA) Reveals Recurrent Proteins Expression Signatures with Prognostic Implications.
    Kornblau, Steven M.
    Qiu, Yi Hua
    Zhang, Nianxiang
    Coombes, Kevin R.
    Graber, David
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    BLOOD, 2010, 116 (21) : 879 - 879
  • [34] TET2 Gene Expression in Bone Marrow Cells in Myelodysplastic Syndromes Patients and the Effect of Silencing TET2 by siRNA On Biological Characteristics of Healthy CD34+Cells
    Shao, Zonghong
    Zhang, Wei
    Fu, Rong
    Li, Lijuan
    Wang, Huaquan
    BLOOD, 2012, 120 (21)
  • [35] Analysis of Aurora kinase A expression in CD34+ blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia
    Ye D.
    Garcia-Manero G.
    Kantarjian H.M.
    Xiao L.
    Vadhan-Raj S.
    Fernandez M.H.
    Nguyen M.H.
    Medeiros L.J.
    Bueso-Ramos C.E.
    Journal of Hematopathology, 2009, 2 (1) : 2 - 8
  • [36] Altered gene expression in CD34+cells from PBSC grafts from patients developing t-MDS following autologous transplantation for lymphoma.
    Li, Liang
    Wu, Xiwei
    Radich, Jerald P.
    Zhao, Lue Ping
    Francisco, Liton
    Komiya, Asako
    Damasco, Holly
    Forman, Stephen J.
    Bhatia, Smita
    Bhatia, Ravi
    BLOOD, 2006, 108 (11) : 659A - 659A
  • [37] The New CD95 Ligand Inhibitor APG101 Leads To Decreased Apoptosis and Improved Erythroid Differentiation In Primary CD34+Cells From Patients With Low Risk Myelodysplastic Syndrome (MDS)
    Nolte, Florian
    Kunz, Claudia
    Fey, Stephanie
    Oblaender, Julia
    Brendel, Susanne
    Klaumuenzer, Marion
    Mossner, Maximilian
    Jann, Johann-Christoph
    Uhlig, Stefanie
    Nowak, Daniel
    Fricke, Harald
    Hofmann, Wolf-Karsten
    BLOOD, 2013, 122 (21)
  • [38] Gene expression profiles of CD34+cells from PBSC grafts predict for development of t-MDS following autologous transplantation for HL/NHL
    Li, Liang
    Wu, Xiwei
    Smith, David
    Radich, Jerald P.
    Zhao, Lue Ping
    Francisco, Liton
    Komiya, Asako
    Damasco, Holly
    Forman, Stephen J.
    Bhatia, Smita
    Bhatia, Ravi
    BLOOD, 2007, 110 (11) : 718A - 718A
  • [39] Identification of defects in the transcriptional program during differentiation of CD34+Cells selected from patients with both, low- and high-risk myelodysplastic syndromes.
    Komor, M
    Gueller, S
    de Vos, S
    Ottmann, OG
    Hoelzer, D
    Hofmann, WK
    BLOOD, 2004, 104 (11) : 61A - 62A
  • [40] Reconstitution of human hematopoiesis in NOD/SCID mice by clonal cells expanded from single CD34+CD38- cells expressing Flk2/Flt3.
    Ebihara, Y
    Wada, M
    Ueda, T
    Mugishima, H
    Asano, S
    Nakahata, T
    Tsuji, K
    BLOOD, 2000, 96 (11) : 664A - 664A
12345